Zobrazeno 1 - 10
of 213
pro vyhledávání: '"Bote, H."'
Autor:
Peressini M; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain., Garcia-Campelo R; Department of Medical Oncology, Hospital Universitario de A Coruña, A Coruña, Spain., Massuti B; Department of Medical Oncology, Hospital General Universitario de Alicante, Alicante, Spain., Martí C; Department of Medical Oncology, Hospital Universitario Sant Joan de Reus, Tarragona, Spain., Cobo M; Department of Medical Oncology, UGC intercentros de Oncología Médica, Hospitales Universitarios Regional y Virgen de la Victoria, IBIMA, Málaga, Spain., Gutiérrez V; Department of Medical Oncology, Complejo Hospitalario Regional de Málaga, Málaga, Spain., Dómine M; Department of Medical Oncology, Hospital Universitario Fundación Jimenez Díaz, Madrid, Spain., Fuentes J; Department of Medical Oncology, Hospital Universitario Virgen de Valme, Sevilla, Spain., Majem M; Department of Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., de Castro J; Department of Medical Oncology, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain., Córdoba JF; Department of Medical Oncology, Hospital Universitario Arnau de Villanova, Lérida, Spain., Diz MP; Department of Medical Oncology, Complejo Asistencial Universitario de León, León, Spain., Isla D; Department of Medical Oncology, Hospital Universitario Lozano Blesa, Zaragoza, Spain., Esteban E; Department of Medical Oncology, Hospital Universitario Central de Asturias, Asturias, Spain., Carcereny E; Department of Medical Oncology, Instituto Catalán de Oncología de Badalona, Badalona-Applied Research Group in Oncology (B-ARGO), Barcelona, Spain., Vila L; Department of Medical Oncology, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Barcelona, Spain., Moreno-Vega A; Department of Medical Oncology, Hospital Universitario Reina Sofia, Córdoba, Spain., Ros S; Department of Medical Oncology, Hospital Universitario Virgen de La Arrixaca, Murcia, Spain., Moreno A; Department of Medical Oncology, Hospital de Galdakao, Vizcaya, Spain., García FJ; Department of Medical Oncology, Hospital Universitario Son Llatzer, Mallorca, Spain., Huidobro G; Department of Medical Oncology, Hospital Universitario Álvaro Cunqueiro, Vigo, Spain., Aguado C; Department of Medical Oncology, Hospital Universitario Clínico San Carlos, Madrid, Spain., Cebey-López V; Department of Medical Oncology, Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain., Valdivia J; Department of Medical Oncology, Hospital Universitario Virgen de las Nieves, Granada, Spain., Palmero R; Department of Medical Oncology, Instituto Catalán de Oncología de Hospitalet de Llobregat, Barcelona, Spain., Lianes P; Department of Medical Oncology, Hospital de Mataró, Barcelona, Spain., López-Brea M; Department of Medical Oncology, Hospital Universitario Marqués de Valdecilla, Santander, Spain., Vidal OJ; Department of Medical Oncology, Hospital Universitario La Fe, Valencia, Spain., Provencio M; Department of Medical Oncology, Hospital Universitario Puerta de Hierro, Madrid, Spain., Arriola E; Department of Medical Oncology, Hospital del Mar, Barcelona, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain., Baena J; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Herrera M; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Bote H; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Molero M; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Adradas V; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Ponce-Aix S; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Nuñez-Buiza A; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain., Ucero Á; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Department of Physiology, Complutense University, Madrid, Spain., Hernandez S; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain., Lopez-Rios F; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Legal Medicine, Psychiatry and Pathology, Complutense University, Madrid, Spain., Conde E; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Pathology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Legal Medicine, Psychiatry and Pathology, Complutense University, Madrid, Spain., Paz-Ares L; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.; Department of Physiology, Complutense University, Madrid, Spain.; Department of Medicine, Complutense University, Madrid, Spain., Zugazagoitia J; Tumor Microenvironment and Immunotherapy Research Group, Instituto de Investigación Hospital 12 de Octubre (i+12), Madrid, Spain.; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Lung Cancer Clinical Research Group, Centro Nacional de Investigaciones Oncológicas (CNIO), Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jul 15; Vol. 30 (14), pp. 3036-3049.
Autor:
Masini, S., Garrido, A., Álvarez, R., Antoñanzas, M., Navarro, F., Traseira, C., Cabezón, L., García, C., Falagan, S., Rocha, P., Mosquera, J., Azkárate, A., García-Lorenzo, E., Martin-Soberón, M.C., Sequero, S., Sereno, M., Lage, Y., Peressini, M., Cortijo, S., Bote, H., Torres-Jiménez, J., Zurera, M., Paz-Ares, L., Zugazagoitia, J., Baena, J.
Publikováno v:
In Journal of Thoracic Oncology October 2024 19(10) Supplement:S405-S405
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Aparicio I; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain; Facultad de Medicina, Universidad Francisco de Vitoria, Pozuelo de Alarcón, Madrid, Spain., Iranzo P; Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology, Barcelona, Spain., Reyes R; Medical Oncology Department, Thoracic Oncology Unit, Hospital Clinic, IDIBAPS, Barcelona, Spain., Bote H; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain;-H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital Universitario 12 de Octubre (i+12), Madrid, Spain., Saigi M; Medical Oncology Department, Hospital Germans Trías i Pujol, Institut Català d'Oncologia-ICO, Badalona, Barcelona, Spain., Bringas M; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Bosch-Barrera J; Medical Oncology, Catalan Institute of Oncology, Hospital Universitari Dr. Josep Trueta, 17007 Girona, Spain. Precision Oncology Group (OncoGIR-Pro), Institut d'Investigació Biomèdica de Girona (IDIBGI), 17190, Salt, Spain., Corral J; Clínica Universidad de Navarra, Department of Oncology, Pamplona, Spain., Aparisi F; Medical Oncology Department, Hospital General Universitario de Valencia, Department of Medicine, Universitat de València, TRIAL Mixed Unit, Centro Investigación Príncipe Felipe-Fundación Investigación Hospital General Universitario de Valencia. CIBERONC, Valencia, Spain., Ruffinelli JC; Medical Oncology Department, Centre Sanitari i Universitari de Bellvitge, Institut Català d'Oncologia (-ICO), L'Hospitalet de Llobregat, Barcelona, Spain., Jiménez B; Hospital HM Universitario Sanchinarro-CIOCC, Madrid, Spain., Lage Y; Medical Oncology Department; Ramón y Cajal University Hospital, Madrid, Spain., López-Castro R; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Majem M; Department of Medical Oncology; Hospital de la Santa Creu i Sant Pau, Barcelona, Spain., Vázquez S; Medical Oncology, Hospital Universitario Lucus Augusti, Lugo, Spain., Artal Á; Medical Oncology Service, Hospital Universitario Miguel Servet, Zaragoza, Spain., Rodríguez-Pérez Á; Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Lázaro-Quintela M; Medical Oncology Department, Hospital Universitario Alvaro Cunqueiro, Vigo, Spain., Torres JMS; Department of Medical Oncology, La Princesa University Hospital, Madrid, Spain., Reguart N; Medical Oncology Department, Thoracic Oncology Unit, Hospital Clinic, IDIBAPS, Barcelona, Spain., Cucurull M; Medical Oncology Department, Hospital Germans Trías i Pujol, Institut Català d'Oncologia-ICO, Badalona, Barcelona, Spain., Gil-Bazo I; Clínica Universidad de Navarra, Department of Oncology, Pamplona, Spain; Instituto Valenciano de Oncología, Department of Oncology, Valencia, Spain., Camps C; Medical Oncology Department, Hospital General Universitario de Valencia, Department of Medicine, Universitat de València, TRIAL Mixed Unit, Centro Investigación Príncipe Felipe-Fundación Investigación Hospital General Universitario de Valencia. CIBERONC, Valencia, Spain., Nadal E; Medical Oncology Department, Centre Sanitari i Universitari de Bellvitge, Institut Català d'Oncologia (-ICO), L'Hospitalet de Llobregat, Barcelona, Spain., Del Barrio A; Hospital HM Universitario Sanchinarro-CIOCC, Madrid, Spain., Garrido P; Medical Oncology Department; Ramón y Cajal University Hospital, Madrid, Spain., Dómine M; Medical Oncology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Álvarez R; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Muñoz AJ; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain., Calles A; Medical Oncology Department, Hospital General Universitario Gregorio Marañón, Universidad Complutense, Madrid, Spain. Electronic address: antonio.calles@salud.madrid.org.
Publikováno v:
Thrombosis research [Thromb Res] 2023 Dec; Vol. 232, pp. 133-137. Date of Electronic Publication: 2023 Nov 12.
Autor:
El Bote H; Sultan Moulay Slimane University, Department of Anatomy, Faculty of Medicine and Pharmacy, Beni-Mellal, Morocco.; Regional Hospital of Beni Mellal, Department of Surgery, Beni-Mellal, Morocco., Lakssir J; University of Rabat, Department of urology A, Ibn Sina Hospital, Rabat, Morocco.
Publikováno v:
The Pan African medical journal [Pan Afr Med J] 2023 Sep 25; Vol. 46, pp. 34. Date of Electronic Publication: 2023 Sep 25 (Print Publication: 2023).
Priapism associated with penile haematoma following a scorpion sting in a child: A rare case report.
Autor:
Bellouki O; Department of Urology A, Ibn Sina University Hospital of Rabat, Morocco., El Bote H; Department of Surgery, Regional Hospital Center of Beni Mellal, Morocco., Lakssir J; Department of Urology A, Ibn Sina University Hospital of Rabat, Morocco., Boughaleb A; Department of Urology A, Ibn Sina University Hospital of Rabat, Morocco., Abaair Y; Department of Urology A, Ibn Sina University Hospital of Rabat, Morocco.
Publikováno v:
Urology case reports [Urol Case Rep] 2023 Jul 19; Vol. 50, pp. 102508. Date of Electronic Publication: 2023 Jul 19 (Print Publication: 2023).
Autor:
El Bote H; Department of Surgery, Regional Hospital Center of Beni Mellal, Morocco., Lakssir J; Department of Urology A, Ibn Sina Hospital, University of Rabat, Morocco., Bellouki O; Department of Urology A, Ibn Sina Hospital, University of Rabat, Morocco., Boughaleb A; Department of Urology A, Ibn Sina Hospital, University of Rabat, Morocco.
Publikováno v:
Urology case reports [Urol Case Rep] 2023 Apr 13; Vol. 48, pp. 102401. Date of Electronic Publication: 2023 Apr 13 (Print Publication: 2023).
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.